Skip to content
Tech News
clear
Topics: Today This Week This Month This Year
1.
Novo Nordisk and Hims End Their Ozempic War. Here’s What It Means for You (gizmodo.com)
2.
A brief history of oral peptides (news.ycombinator.com)
3.
Hims & Hers is scrapping its plan for a knockoff Wegovy weight-loss pill. Here’s why (feeds.feedburner.com)
4.
Dow 50,000, Super Bowl 60, Meta's big week in court and more in Morning Squawk (cnbc.com)
5.
Novo Nordisk Furious at $49 Knockoff Ozempic Pill (futurism.com)
6.
I Really Hope the New ‘Ghost in the Shell’ Anime Keeps the Major’s Manga Goofiness (gizmodo.com)
7.
He Went From Food Stamps to Co-Founding a $9.3 Billion Startup. Here's Why He Walked Away. (feeds.feedburner.com)
8.
Hims & Hers stock falls 10% on revenue miss (cnbc.com)
9.
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs (gizmodo.com)
10.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
11.
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: apple nvidia openai amazon google meta android authority chatgpt android samsung
View all today's topics →